Research and Markets: The Oncology Systems Segment is Varian Medical Systems Largest, Accounting for 83% of the Company's Revenue in 2006.DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c50754) has announced the addition of the Espicom Business Intelligence Introduction Espicom Business Intelligence is a publisher of independent and impartial information and analysis services focusing on the pharmaceutical and medical device markets. Ltd report: Varian Medical Device Company Intelligence Report to their offering. Varian Medical Systems Varian Medical Systems (NYSE: VAR) is engaged in the design and manufacture of advanced equipment and software solutions for treating cancer with radiation, as well as x-ray tubes for original equipment manufacturers, replacement x-ray tubes and flat-panel digital subsystems (VMS (1) (Virtual Memory System) A multiuser, multitasking, virtual memory operating system for the VAX series from Digital. VMS applications run on any VAX from the MicroVAX to the largest unit. See OpenVMS. ), headquartered in Palo Alto, California “Palo Alto” redirects here. For other uses, see Palo Alto (disambiguation). Palo Alto (IPA: /ˌpæloʊˈʔæltoʊ/, from Spanish: palo: "stick" and alto: "high", i.e. , USA, designs and manufactures integrated equipment and software for treating cancer with radiation therapy, as well as radiosurgery radiosurgery /ra·dio·sur·gery/ (-ser´jer-e) surgery in which tissue destruction is performed by means of ionizing radiation rather than by surgical incision. and brachytherapy products, X-ray tubes for original equipment manufacturers, replacement X-ray tubes and flat panel imaging detectors. The company also offers a range of products for the industrial and non-destructive testing markets, which are not covered not covered Health care adjective Referring to a procedure, test or other health service to which a policy holder or insurance beneficiary is not entitled under the terms of the policy or payment system–eg, Medicare. Cf Covered. by this profile. VMS has manufacturing facilities in the US, Switzerland, France, the UK, Finland, Germany, Japan and Canada. The company is also building a new plant in Beijing, China, to manufacture linear accelerators and has recently expanded manufacturing capacity in the US for its X-ray products business. VMS' medical products are classified into three categories: Oncology Systems, X-ray Products and Other, including the Security and Inspection Products (SIP) business and the Ginzton Technology Center (GTC GTC See: Good 'til cancelled order GTC See good-till-canceled order (GTC). ). At the beginning of fiscal 2006, VMS separated SIP from Oncology Systems and reported it with GTC under the Other category. Concurrently, it moved the brachytherapy unit from the Other category to Oncology Systems. The Oncology Systems segment is VMS' largest, accounting for 83% of the company's revenue in fiscal 2006, while the X-ray Products unit generated 14% of sales and Other revenue accounted for 4%. Of the company's 3,900 employees in fiscal 2006, 2,983 were based in the Oncology Systems division and 564 at X-ray Products. VMS' main focus and the area for which it is best known is its radiation oncology radiation oncology n. The branch of radiology that deals with the use of ionizing radiation to treat cancers. radiation oncology products. The company is the world's leading supplier of radiotherapy systems for treating cancer. There are more than 6,100 radiotherapy centres worldwide and VMS equips nearly half of these with its products. The company believes there are over 4,750 of its Clinac and Trilogy medical linear accelerators and Acuity treatment planning, simulation and verification systems in service around the world, treating thousands of cancer patients each day. The Oncology Systems unit offers linear accelerators, treatment simulation and verification products, information management and treatment planning software, brachytherapy products, software, accessories and services. These products enable radiation oncology departments to perform conventional radiotherapy, intensity-modulated radiation therapy intensity-modulated radiation therapy See IMRT. (IMRT IMRT Intensity-modulated radiation therapy Radiation oncology A format for delivering high-dose RT to regions–eg, nasopharynx, that are surrounded by radiation-sensitive areas; in IMRT, a broad radiation field is divided into hundreds of small pencil beams, ), image-guided radiation therapy Image-guided radiation therapy (IGRT) is the process of frequent two and three-dimensional imaging, during a course of radiation treatment, used to direct radiation therapy utilizing the imaging coordinates of the actual radiation treatment plan. (IGRT IGRT Image Guided Radiation Therapy ), stereotactic radiosurgery and stereotactic stereotactic /ster·eo·tac·tic/ (-tak´tik) 1. characterized by precise positioning in space; said especially of discrete areas of the brain that control specific functions. 2. pertaining to stereotactic surgery. radiotherapy, as well brachytherapy. The division's current growth is coming from demand for the latest oncology technology, IGRT, which can be conducted using VMS' On-Board Imager (OBI) device. The adoption of VMS' IGRT products is occurring three times faster than the company experienced with the introduction of IMRT earlier this decade, and this growth is particularly strong in the US. In January 2005, VMS formed Varian Surgical Sciences, an organisation within the Oncology Systems unit focused on the use of the company's imaging and treatment technologies for image-guided radiosurgery. The organisation markets products built around the Trilogy linear accelerator and OBI device. In addition, a dedicated image-guided radiosurgery system, Trilogy Tx, was launched in May 2006. VMS' X-ray Products unit offers X-ray tubes for use in computed tomography (CT), radioscopic/fluoroscopic imaging, mammography mammography, diagnostic procedure that uses low-dose X rays to detect abnormalities in the breasts. The early diagnosis of breast cancer made possible by the routine use of mammography for screening women increases a woman's treatment alternatives and improves her , special procedures and industrial applications, and flat panel detectors for digital X-ray image capture. The products are sold to large OEMs that incorporate the components and subsystems into their medical and industrial imaging systems. The X-ray tubes are also sold directly to end-users for replacement purposes, while the flat panel detectors are also incorporated into VMS' IGRT products. After years of investment in flat panel technology, these products have become a significant contributor to VMS' X-ray Products segment and are expected to become its main revenue source within a few years, overtaking sales of X-ray tubes. However, due to the strong demand, VMS experienced production capacity issues which limited sales in 2006. It is currently increasing its manufacturing operations to overcome this problem. VMS' SIP unit offers Linatron X-ray accelerators for security and inspection purposes, while the GTC develops technologies to enhance VMS' current businesses or to lead to new areas, including next-generation digital X-ray imaging, volumetric volumetric /vol·u·met·ric/ (vol?u-met´rik) pertaining to or accompanied by measurement in volumes. vol·u·met·ric adj. Of or relating to measurement by volume. and functional imaging, new X-ray sources and technology for security and cargo screening. GTC also develops technologies to improve disease management by the more precise targeting of radiation, as well as by employing targeted energy and molecular agents to enhance the effectiveness and broaden the application of radiation therapy. In addition, VMS has recently acquired ACCEL ACCEL Accelerate ACCEL Accelerometer ACCEL Accelerando (Music, Gradually Increasing in Speed) ACCEL American College of Cardiology Extended Learning Instruments GmbH, a privately-held supplier of proton therapy systems for cancer treatment and scientific research instruments. ACCEL, based in Bergisch Gladbach near Cologne, Germany, has annual sales of around US$25 million. The acquisition will enable VMS to offer products for delivering image-guided, intensity-modulated proton therapy for cancer patients. According to the company, customers have begun to ask for proton therapy capabilities that supplement their existing radiotherapy systems. The transaction will enable VMS to do this, and also leverages its existing technology in treatment planning, image guidance and cancer informatics. The company believes it can build a several hundred million dollar proton therapy business over time. Topics Covered Executive Summary Overview Strategic Focus Product Portfolio and R&D Oncology Systems X-Ray Products Other Products Research and Development International Activities Operating Locations Appendices Appendix 1 - Financial Indicators Appendix 2 - Key Corporate Events Appendix 3 - Mergers and Acquisitions Appendix 4 - Joint Ventures Appendix 5 - Minority Investments Appendix 6 - Divestitures Appendix 7 - Agreements Appendix 8 - Litigation For more information visit http://www.researchandmarkets.com/reports/c50754. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion